Vitamin D3 2000 IU®

Vitamins

Brand: Enzymatic Therapy

Tablet or PillVitaminOff Market
Click to view full label

Net Contents

90 Sugar-Free Chewable Tablet(s)

Serving Size

1 Tablet(s)

Servings Per Container

Not specified

Supplement Form

Tablet or Pill

Bar Code (UPC/SKU)

7 63948 06919 4

Product Version

LC06919.04

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

1Active Ingredients

Single-ingredient formula listed in Supplement Facts.

100%Amount Transparency

Every active ingredient discloses a specific amount per serving.

1% Daily Value Coverage

1 ingredients report a %DV; 1 meet or exceed 100% DV.

1Dietary Attributes

Label states: Gluten-Free.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Allergen Guide

Contains

  • Milk
  • Wheat
  • Soy
  • Gluten

Allergen flags are parsed automatically from the official label's claims and statements. Always verify against the physical product label before use, especially if you have a severe allergy.

Supplement Facts

Serving Size: 1 Tablet(s) · 1 per day

IngredientAmount Per Serving% Daily Value
Vitamin D(Cholecalciferol)2000 IU500%

Not Present

Other Ingredients

organic inulinSorbitolMannitolNatural flavorsCocoa bean powderMaltodextrinErythritolMagnesium StearateCarnauba WaxSilicon Dioxide

Target Groups

Adult (18 - 50 Years)Gluten FreeDairy FreeSugar Free

Label Claims

All OtherStructure/Function

Directions & Suggested Use

Suggested/Recommended/Usage/Directions

Recommendations: One tablet daily. Best when taken with meals.

Warnings & Precautions

Precautions re: Pregnant or Nursing or Prescription Medications

If pregnant, nursing, or taking prescription drugs, consult your healthcare practitioner prior to use.

Formulation

Formulation re: Does NOT Contain

Contains no sugar, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial coloring, artificial flavoring, or preservatives.

FDA Statements

FDA Disclaimer Statement

THIS STATEMENT HAS NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.

FDA Statement of Identity

DIETARY SUPPLEMENT

Other Label Statements

General Statements: All Other Content

This product contains natural ingredients; color variations are normal.

General Statements: All Other Content

Clinical studies have shown that increased intake of Vitamin D3 boosts calcium absorption. Vitamin D3 provides a convenient way to increase intake of the bioactive form of Vitamin D as it promotes: ~Healthy bones and teeth ~A strong immune system ~Healthy cell growth and development

General Statements: All Other Content

ETI is an FDA-registered Drug Establishment.

Seals/Symbols

LABORATORY TESTED PURITY, SAFETY & PERFORMANCE

General: Product/Version Code

LC06919.04

General Statements: All Other Content

Supports strong bones, teeth, and a healthy immune system

Seals/Symbols

Enzymatic Therapy What Better Feels Like(R)

General Statements: All Other Content

GREAT-TASTING CHOCOLATE CHEWABLE!

Manufacturer & Distributor

Manufacturer

Enzymatic Therapy, Inc.

Green Bay, WI, 54311, USA

1.800.783.2286

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • Vitamin D3 Therapy Corrects the Tissue Sensitivity to Angiotensin II Akin to the Action of a Converting Enzyme Inhibitor in Obese Hypertensives: An Interventional …

    A Vaidya, B Sun, C Larson, JP Forman… - The Journal of …, 2012 - academic.oup.com

    … We hypothesized that high-dose vitamin D 3 therapy in obese individuals with low vitamin D … , and after, 1 month of vitamin D 3 15,000 IU/d therapy. These studies were conducted with …

    2012101 citations
  • Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study

    P Chandra, JNG Binongo, TR Ziegler, LE Schlanger… - Endocrine Practice, 2008 - Elsevier

    … filtration rate, 15-59 mL/min/1.73 m 2 ), vitamin D insufficiency (serum 25[OH]D < 30 ng/mL), … IU of cholecalciferol or placebo once weekly for 12 weeks. Primary outcomes (25[OH]D and …

    2008190 citations
  • Vitamin D3 as an immunomodulatory agent: molecular mechanisms, clinical translation, and precision therapeutic strategies

    Q Liu, Z Li, S Li, Y Li, H Pan, Y Tao - Frontiers in Immunology, 2026 - frontiersin.org

    … D receptor (VDR) but also possess the complete enzymatic machinery required for local Vitamin D 3 metabolism activation ( 2 ). Epidemiological studies consistently demonstrate …

    20265 citations
  • Evaluation of vitamin D3 intakes up to 15,000 international units/day and serum 25-hydroxyvitamin D concentrations up to 300 nmol/L on calcium metabolism in a …

    SM Kimball, N Mirhosseini, MF Holick - Dermato-endocrinology, 2017 - Taylor & Francis

    … Vitamin D 3 intakes of at least 6,000 IU/d were required for those with a normal BMI to achieve serum 25(OH)D concentrations above 100 nmol/L, or 7,000 IU/d and 8,000 IU/d for …

    201791 citations
  • … 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency–a …

    U Kampmann, L Mosekilde, C Juhl, N Moller… - Metabolism, 2014 - Elsevier

    … Serum-25(OH) vitamin D and serum-1,25(OH) 2 vitamin D increased significantly after 12 … Serum-25(OH) vitamin D was also significantly higher in the vitamin D group compared to the …

    2014217 citations
  • Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: áaárandomized study

    A Rorie, WS Goldner, E Lyden, JA Poole - Annals of allergy, asthma & …, 2014 - Elsevier

    … showed symptom alleviation after vitamin D 2 supplementation (50,000 IU/week) … vitamin D 3 supplementation (2,000 IU/d for approximately 2 months) in a patient with profound vitamin …

    2014107 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2013-09-25. DSLD Label ID: 25553. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.